van der Lely, A J <br/><br/>
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist.  [electronic resource] 

 -  Lancet (London, England)  Nov 2001 
 - 1754-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0140-6736 
<br/><br/><label>Standard No.: </label>10.1016/s0140-6736(01)06844-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acromegaly--drug therapy<br/>Adult<br/>Blood Glucose--drug effects<br/>Cohort Studies<br/>Drug Administration Schedule<br/>Female<br/>Growth Hormone--blood<br/>Human Growth Hormone--analogs & derivatives<br/>Humans<br/>Insulin--blood<br/>Insulin-Like Growth Factor I--metabolism<br/>Male<br/>Middle Aged<br/>Receptors, Somatotropin--antagonists & inhibitors